Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2015 1
2016 1
2020 1
2021 3
2022 3
2023 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
The incremental value of the contribution of a biostatistician to the reporting quality in health research-A retrospective, single center, observational cohort study.
Held U, Steigmiller K, Hediger M, Cammann VL, Garaiman A, Halvachizadeh S, Losdat S, West EA, Gosteli M, Reeve KA, von Felten S, Furrer E. Held U, et al. Among authors: garaiman a. PLoS One. 2022 Mar 4;17(3):e0264819. doi: 10.1371/journal.pone.0264819. eCollection 2022. PLoS One. 2022. PMID: 35245326 Free PMC article.
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model.
Garaiman A, Steigmiller K, Gebhard C, Mihai C, Dobrota R, Bruni C, Matucci-Cerinic M, Henes J, de Vries-Bouwstra J, Smith V, Doria A, Allanore Y, Dagna L, Anić B, Montecucco C, Kowal-Bielecka O, Martin M, Tanaka Y, Hoffmann-Vold AM, Held U, Distler O, Becker MO; EUSTAR Collaborators. Garaiman A, et al. Rheumatology (Oxford). 2023 Feb 6;62(SI):SI91-SI100. doi: 10.1093/rheumatology/keac405. Rheumatology (Oxford). 2023. PMID: 35904554
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire.
Becker MO, Dobrota R, Garaiman A, Debelak R, Fligelstone K, Tyrrell Kennedy A, Roennow A, Allanore Y, Carreira PE, Czirják L, Denton CP, Hesselstrand R, Sandqvist G, Kowal-Bielecka O, Bruni C, Matucci-Cerinic M, Mihai C, Gheorghiu AM, Mueller-Ladner U, Sexton J, Kvien TK, Heiberg T, Distler O. Becker MO, et al. Among authors: garaiman a. Ann Rheum Dis. 2022 Apr;81(4):507-515. doi: 10.1136/annrheumdis-2021-220702. Epub 2021 Nov 25. Ann Rheum Dis. 2022. PMID: 34824049
Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort.
Scheidegger M, Boubaya M, Garaiman A, Barua I, Becker M, Bjørkekjær HJ, Bruni C, Dobrota R, Fretheim H, Jordan S, Midtvedt O, Mihai C, Hoffmann-Vold AM, Distler O, Elhai M. Scheidegger M, et al. Among authors: garaiman a. RMD Open. 2024 Jan 9;10(1):e003658. doi: 10.1136/rmdopen-2023-003658. RMD Open. 2024. PMID: 38199606 Free PMC article.
Mitochondrial respiratory complex I probed by delayed luminescence spectroscopy.
Baran I, Ionescu D, Privitera S, Scordino A, Mocanu MM, Musumeci F, Grasso R, Gulino M, Iftime A, Tofolean IT, Garaiman A, Goicea A, Irimia R, Dimancea A, Ganea C. Baran I, et al. Among authors: garaiman a. J Biomed Opt. 2013 Dec;18(12):127006. doi: 10.1117/1.JBO.18.12.127006. J Biomed Opt. 2013. PMID: 24365956 Free article.
15 results